Skip to content

Rensihaw PLC

United KingdomFDA applicant, unverified

Devices
1

What Rensihaw PLC makes

Rensihaw Plc manufactures the neuro inspire, a device designed for neuromodulation therapy to manage neurological conditions.

The neuro inspire is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • neuro inspire Ref K163666

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Rensihaw Plc have in the registry?

The registry currently lists 1 device for Rensihaw Plc. Devices recorded under merged duplicate company entries are counted once.

Which registries list Rensihaw Plc's devices?

Among its 1 most recently registered device, Rensihaw Plc has devices listed in FDA 510(k) (1 device).

What risk classes do Rensihaw Plc's devices fall under?

Among its 1 most recently registered device, the classes recorded for Rensihaw Plc's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Rensihaw Plc in the registry?

The most recently registered devices listed for Rensihaw Plc include neuro inspire.

Generated automatically from registry data and not verified by a human reviewer.